help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meduri, G. U.
Right arrow Articles by Stentz, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meduri, G. U.
Right arrow Articles by Stentz, F.

Am. J. Respir. Crit. Care Med., Volume 165, Number 7, April 2002, 983-991

Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress Syndrome
Evidence for Inadequate Endogenous Glucocorticoid Secretion and Inflammation-induced Immune Cell Resistance to Glucocorticoids

G. Umberto Meduri, Elizabeth A. Tolley, George P. Chrousos, and Frankie Stentz

Memphis Lung Research Program, Divisions of Pulmonary and Critical Care Medicine, Department of Medicine, and Department of Preventive Medicine, University of Tennessee, Memphis, Tennessee; and Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland

Nuclear factor-kappa B (NF-kappa B) and glucocorticoid receptor-alpha (GR-alpha ) have diametrically opposed functions in regulating inflammation. We investigated whether unresolving acute respiratory distress syndrome (ARDS) is associated with systemic inflammation- induced glucocorticoid resistance and whether prolonged methylprednisolone administration accelerates the suppression of systemic inflammatory indices and normalizes the sensitivity of the immune system to glucocorticoids. Patients enrolled into a randomized trial evaluating prolonged methylprednisolone administration in unresolving ARDS had serial plasma samples collected before and after randomization. In the plasma, we measured the concentrations of tumor necrosis factor-alpha (TNF-alpha ), interleukins (IL) IL-1beta and IL-6, adrenocorticotropic hormone (ACTH), and cortisol. The ability of patient plasma to influence the NF-kappa B and GR-signal transduction systems of normal peripheral blood leukocytes (PBL) was examined. Patients treated with methylprednisolone had progressive and sustained reductions of TNF-alpha , IL-1beta , IL-6, ACTH, and cortisol concentrations over time. Normal PBL exposed to plasma samples collected during methylprednisolone exhibited significant progressive increases in all aspects of GR-mediated activity and significant reductions in NF-kappa B DNA-binding and transcription of TNF-alpha and IL-1beta . These findings provide support for the presence of endogenous glucocorticoid inadequacy in the control of inflammation and systemic inflammation-induced peripheral glucocorticoid resistance in ARDS. Prolonged methylprednisolone administration accelerated the resolution of both systemic inflammation and peripheral acquired glucocorticoid resistance in ARDS.




This article has been cited by other articles:


Home page
J Intensive Care MedHome page
K. M. Schuster, R. Alouidor, and E. S. Barquist
Nonventilatory Interventions in the Acute Respiratory Distress Syndrome
J Intensive Care Med, January 1, 2008; 23(1): 19 - 32.
[Abstract] [PDF]


Home page
Canadian J. AnesthesiaHome page
M. A. Ewanchuk and M. J. Jacka
Steroids in fibroproliferative acute respiratory distress syndrome: approach with care
Can J Anesth, September 1, 2007; 54(9): 765 - 766.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
Z. Thomas and G. L Fraser
An Update on the Diagnosis of Adrenal Insufficiency and the Use of Corticotherapy in Critical Illness
Ann. Pharmacother., September 1, 2007; 41(9): 1456 - 1465.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
S. K Gorman, R. S Slavik, and J. Marin
Corticosteroid Treatment of Severe Community-Acquired Pneumonia
Ann. Pharmacother., July 1, 2007; 41(7): 1233 - 1237.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Annane
Glucocorticoids for ARDS: Just Do It!
Chest, April 1, 2007; 131(4): 945 - 946.
[Full Text] [PDF]


Home page
ChestHome page
G. U. Meduri, E. Golden, A. X. Freire, E. Taylor, M. Zaman, S. J. Carson, M. Gibson, and R. Umberger
Methylprednisolone Infusion in Early Severe ARDS*Results of a Randomized Controlled Trial
Chest, April 1, 2007; 131(4): 954 - 963.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S.R BORNSTEIN, C.G ZIEGLER, A.W KRUG, W KANCZKOWSKI, V RETTORI, S.M MCCANN, M WIRTH, and K ZACHAROWSKI
The Role of Toll-like Receptors in the Immune-Adrenal Crosstalk
Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 307 - 318.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. Arafah
Hypothalamic Pituitary Adrenal Function during Critical Illness: Limitations of Current Assessment Methods
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3725 - 3745.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R.-c. Chen, X.-p. Tang, S.-y. Tan, B.-l. Liang, Z.-y. Wan, J.-q. Fang, and N. Zhong
Treatment of Severe Acute Respiratory Syndrome With Glucosteroids: The Guangzhou Experience
Chest, June 1, 2006; 129(6): 1441 - 1452.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Margeli, K. Skenderi, M. Tsironi, E. Hantzi, A.-L. Matalas, C. Vrettou, E. Kanavakis, G. Chrousos, and I. Papassotiriou
Dramatic Elevations of Interleukin-6 and Acute-Phase Reactants in Athletes Participating in the Ultradistance Foot Race Spartathlon: Severe Systemic Inflammation and Lipid and Lipoprotein Changes in Protracted Exercise
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3914 - 3918.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S Vale
Psychosocial stress and cardiovascular diseases
Postgrad. Med. J., July 1, 2005; 81(957): 429 - 435.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. K. Andersson, M. Chaduvula, S. E. Atkinson, S. Khanolkar-Young, S. Jain, L. Suneetha, S. Suneetha, and D. N. J. Lockwood
Effects of Prednisolone Treatment on Cytokine Expression in Patients with Leprosy Type 1 Reactions
Infect. Immun., June 1, 2005; 73(6): 3725 - 3733.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi, G. Puccio, R. Della Porta, C. Giorgio, F. Blasi, R. Umberger, et al.
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 242 - 248.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Puneet, S. Moochhala, and M. Bhatia
Chemokines in acute respiratory distress syndrome
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L3 - L15.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
E. S. Nylen and B. Muller
Endocrine Changes in Critical Illness
J Intensive Care Med, March 1, 2004; 19(2): 67 - 82.
[Abstract] [PDF]


Home page
Eur Respir JHome page
P. Dahlem, W.M.C. van Aalderen, M.E. Hamaker, M.G.W. Dijkgraaf, and A.P. Bos
Incidence and short-term outcome of acute lung injury in mechanically ventilated children
Eur. Respir. J., December 1, 2003; 22(6): 980 - 985.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Avitsur, D. A. Padgett, F. S. Dhabhar, J. L. Stark, K. A. Kramer, H. Engler, and J. F. Sheridan
Expression of glucocorticoid resistance following social stress requires a second signal
J. Leukoc. Biol., October 1, 2003; 74(4): 507 - 513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. R. M. Rocco, A. B. Souza, D. S. Faffe, C. P. Passaro, F. B. Santos, E. M. Negri, J. G. M. Lima, R. S. Contador, V. L. Capelozzi, and W. A. Zin
Effect of Corticosteroid on Lung Parenchyma Remodeling at an Early Phase of Acute Lung Injury
Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 677 - 684.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. Fernandez-Serrano, J. Dorca, M. Coromines, J. Carratala, F. Gudiol, and F. Manresa
Molecular Inflammatory Responses Measured in Blood of Patients with Severe Community-Acquired Pneumonia
Clin. Vaccine Immunol., September 1, 2003; 10(5): 813 - 820.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G.U. Meduri, P. Carratu, and A.X. Freire
Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS
Eur. Respir. J., August 1, 2003; 22(42_suppl): 57s - 64s.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. B. Waxman, J.-A. O. Shepard, and E. J. Mark
Case 14-2003 - A 73-Year-Old Woman with Pneumonia and Progressive Respiratory Failure
N. Engl. J. Med., May 8, 2003; 348(19): 1902 - 1912.
[Full Text] [PDF]


Home page
NEJMHome page
M. S. Cooper and P. M. Stewart
Corticosteroid Insufficiency in Acutely Ill Patients
N. Engl. J. Med., February 20, 2003; 348(8): 727 - 734.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. R. Bornstein and J. Briegel
A New Role for Glucocorticoids in Septic Shock: Balancing the Immune Response
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 485 - 486.
[Full Text] [PDF]


Home page
Innate ImmunityHome page
A. Beishuizen and L. G. Thijs
Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis
Innate Immunity, February 1, 2003; 9(1): 3 - 24.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Critical Care Medicine in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 294 - 305.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Sasaki, S. Fujishima, H. Iwamura, K. Wakitani, S. Aiso, and N. Aikawa
Prior burn insult induces lethal acute lung injury in endotoxemic mice: effects of cytokine inhibition
Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L270 - L278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kino and G. P. Chrousos
Tumor Necrosis Factor alpha Receptor- and Fas-associated FLASH Inhibit Transcriptional Activity of the Glucocorticoid Receptor by Binding to and Interfering with Its Interaction with p160 Type Nuclear Receptor Coactivators
J. Biol. Chem., January 24, 2003; 278(5): 3023 - 3029.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society